Brief introduction of 1003-21-0

The synthetic route of 1003-21-0 has been constantly updated, and we look forward to future research findings.

In the next few decades, the world population will flourish. As the population grows rapidly and people all over the world use more and more resources, all industries must consider their environmental impact. 1003-21-0, name is 5-Bromo-1-methyl-1H-imidazole belongs to imidazoles-derivatives compound, it is a common compound, a new synthetic route is introduced below. 1003-21-0

Example 27: N-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenyl)-3-{4-[2- (1-hydroxy-1-methyl-ethyl)-3-methyl-3H-imidazol-4-yl]- [1, 2,3] triazol-1-yl}-4- methyl-benzamide; Ethyl chloroformate (1.19 mL, 12.4 mmol) in MeCN (5 mL) was added dropwise to a 1.00 g (6.21 mmol) of 5-bromo-1-methyl-1H-imidazole (Aldrich) in 30 mL of MeCN under N2. The mixture was stirred and allowed to warm to rt overnight. The mixture was concentrated and the residue was treated with 2M NaOH (100 mL) and extracted with CHUCK (3 x 100 mL). The combined extracts were washed with brine, dried with MgS04, filtered, concentrated, and chromatographed (0-50% EtOAc in hexanes) to give the 5-bromo-1-methyl-lH-imidazole-2-carboxylic acid ethyl ester as a yellow oil (800 mg).

The synthetic route of 1003-21-0 has been constantly updated, and we look forward to future research findings.

Reference:
Patent; BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.; WO2005/90333; (2005); A1;,
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem